Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Deadline for Applications July 19, 2026 Hardship Level H (no hardship) Family Type Family Residential location (if applicable) Grade PR2 Staff Member / Affiliate Type Junior Professional Officer ReasonRegular Regular Assignment Target Start Date 2026-07-01 Standard
Description and will be considered for the screening, shortlisting and selection of candidates. Desired Candidate Profile This job is advertised in the framework of the JPO Programme and reserved exclusively for candidates with Canadian nationality. OPERATIONAL